A
ACEA Therapeutics, Inc
Profile managed by Bizz IdACEA Therapeutics
Estados Unidos
11-50 employees
Description
Clinical-stage pharmaceutical company headquartered in San Diego, CA. Develops therapies for cancer, autoimmune diseases and COVID-19. Key products: Olgotrelvir (dual SARS-CoV-2 inhibitor) and Abivertinib (kinase inhibitor for NSCLC). Subsidiary of Scilex Holding Company.